328 related articles for article (PubMed ID: 241839)
21. Mechanism of lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.
Saulnier-Blache JS; Taouis M; Dauzats M; Uzan A; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1989 Dec; 251(3):1193-8. PubMed ID: 2481031
[TBL] [Abstract][Full Text] [Related]
22. Cyclic AMP regulation of fuel metabolism during exercise: regulation of adipose tissue lipolysis during exercise.
Shepherd RE; Bah MD
Med Sci Sports Exerc; 1988 Dec; 20(6):531-8. PubMed ID: 2853268
[TBL] [Abstract][Full Text] [Related]
23. Hormonal regulation of lipolysis and phosphorylase activity in human fat cells.
Moskowitz J; Fain JN
J Clin Invest; 1969 Oct; 48(10):1802-8. PubMed ID: 4309801
[TBL] [Abstract][Full Text] [Related]
24. Multiple symmetric lipomatosis: a defect in adrenergic-stimulated lipolysis.
Enzi G; Inelmen EM; Baritussio A; Dorigo P; Prosdocimi M; Mazzoleni F
J Clin Invest; 1977 Dec; 60(6):1221-9. PubMed ID: 199616
[TBL] [Abstract][Full Text] [Related]
25. Specific inhibition by prostaglandins E2 and I2 of histamine-stimulated [14C]aminopyrine accumulation and cyclic adenosine monophosphate generation by isolated canine parietal cells.
Soll AH
J Clin Invest; 1980 May; 65(5):1222-9. PubMed ID: 6154063
[TBL] [Abstract][Full Text] [Related]
26. A comparison of the effects of lipolytic and antilipolytic agents on adenosine 3',5'-monophosphate levels in adipose cells as determined by prior labeling with adenine-8-14C.
Kuo JF; De Renzo EC
J Biol Chem; 1969 May; 244(9):2252-60. PubMed ID: 4306506
[TBL] [Abstract][Full Text] [Related]
27. Human fat cell lipolysis is primarily regulated by inhibitory modulators acting through distinct mechanisms.
Kather H; Bieger W; Michel G; Aktories K; Jakobs KH
J Clin Invest; 1985 Oct; 76(4):1559-65. PubMed ID: 2997284
[TBL] [Abstract][Full Text] [Related]
28. Effect of histamine of lipolysis and adenosine 3',5'-monophosphate levels in canine adipose tissue.
Grund VR; Goldberg ND; Hunninghake DB
Biochem Pharmacol; 1973 Mar; 22(6):769-72. PubMed ID: 4348314
[No Abstract] [Full Text] [Related]
29. The effects of the immunologic release of histamine upon human lung cyclic nucleotide levels and prostaglandin generation.
Platshon LF; Kaliner M
J Clin Invest; 1978 Dec; 62(6):1113-21. PubMed ID: 85634
[TBL] [Abstract][Full Text] [Related]
30. The effects of the H1 and H2 antihistamines on "allergic" histamine release and its inhibition by histamine.
Lichtenstein LM; Gillespie E
J Pharmacol Exp Ther; 1975 Feb; 192(2):441-50. PubMed ID: 46921
[TBL] [Abstract][Full Text] [Related]
31. Effects of drugs influencing gastric secretion on the quantitative histological distribution of cyclic adenosine 3':5'-monophosphate in the rat stomach.
Katsumata Y; Glick D
Gastroenterology; 1975 Aug; 69(2):409-15. PubMed ID: 168122
[TBL] [Abstract][Full Text] [Related]
32. Adenosine A1 receptors regulate lipolysis and lipogenesis in mouse adipose tissue-interactions with insulin.
Johansson SM; Lindgren E; Yang JN; Herling AW; Fredholm BB
Eur J Pharmacol; 2008 Nov; 597(1-3):92-101. PubMed ID: 18789919
[TBL] [Abstract][Full Text] [Related]
33. Relationships between cyclic AMP levels and lipolysis in fat cells after isoproterenol and forskolin stimulation.
Allen DO; Ahmed B; Naseer K
J Pharmacol Exp Ther; 1986 Aug; 238(2):659-64. PubMed ID: 3016246
[TBL] [Abstract][Full Text] [Related]
34. The effect of histamine, isoproterenol and tyramine on rat uterine cyclic AMP.
Verma SC; McNeill JH
Res Commun Chem Pathol Pharmacol; 1976 Jan; 13(1):55-64. PubMed ID: 176705
[TBL] [Abstract][Full Text] [Related]
35. [Adrenergic lipolysis in human fat cells: properties and physiological role of alpha-adrenergic receptors (author's transl)].
Berlan M; Lafontan M; Dang Tran L
J Physiol (Paris); 1980; 76(2):133-46. PubMed ID: 6249915
[TBL] [Abstract][Full Text] [Related]
36. Possible involvement of adenosine 3':5'-cyclic monophosphate and extracellular calcium ions in histamine stimulation of interleukin-1 release from macrophage-like P388D1 cells.
Okamoto H; Oh C; Nakano K
Immunology; 1990 Jun; 70(2):186-90. PubMed ID: 2165034
[TBL] [Abstract][Full Text] [Related]
37. Adenosine release from fat cells: effect on cyclic AMP levels and hormone actions.
Schwabe U; Ebert R; Erbler HC
Adv Cyclic Nucleotide Res; 1975; 5():569-84. PubMed ID: 165687
[No Abstract] [Full Text] [Related]
38. Effects of lipolytic and antilipolytic agents on glycerol and free fatty acid release from isolated adipocytes of normal and diabetic rats.
Kamei I; Hotta N; Kakuta H; Kimura M; Fukasawa H; Koh N; Sakamoto N
Nagoya J Med Sci; 1989 Mar; 51(1-4):17-23. PubMed ID: 2549422
[TBL] [Abstract][Full Text] [Related]
39. Effect of histamine and its methyl derivatives on cyclic AMP metabolism in gastric mucosa and its blockade by an H2 receptor antagonist.
Dousa TP; Code CF
J Clin Invest; 1974 Jan; 53(1):334-7. PubMed ID: 4148625
[TBL] [Abstract][Full Text] [Related]
40. Regulation of cyclic AMP metabolism and lipolysis in isolated rat fat cells by insulin, N6-(phenylisopropyl) adenosine and 2',5'-dideoxyadenosine.
Fain JN; Li SY; Moreno FJ
J Cyclic Nucleotide Res; 1979; 5(3):189-96. PubMed ID: 225356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
